Ontario Health - Cancer Care Ontario's Data Book - 2021-2022 |
|
Updated in October 2019
Entity
|
Data Element |
Definition
|
Format
|
Valid Values
|
Purpose and Use
|
Changes
|
|
Patient |
Facility ID |
The Facility code of the RCC applying for reimbursement. |
VARCHAR(4) |
4 digit numerical entry. Refer to Appendix A for codes. |
Used to identify the RCC for the purpose of determining eligibility for brachytherapy reimbursement and for health system planning. |
||
Patient |
Medical Record Number |
Internal patient identifier in the hospital. |
VARCHAR2 (12) |
12-digit numerical entry. |
Used to identify the patient for the purpose of determining eligibility for brachytherapy reimbursement and for health system planning. |
|
|
Patient |
Ontario Health Insurance Number |
The OHIN number of the patient requesting brachytherapy reimbursement. |
VARCHAR2 (12) |
10-digit numerical entry. |
Used to identify the patient for the purpose of reimbursement and health system planning. |
||
Patient |
Patient Surname |
The surname of the patient requesting brachytherapy reimbursement. |
VARCHAR2 (20) |
Alphabetic entry. |
Used to identify the patient for the purpose of determining eligibility for brachytherapy reimbursement and for health system planning. |
|
|
Patient |
Patient First Name |
The first name of the patient requesting brachytherapy reimbursement. |
VARCHAR2 (15) |
Alphabetic entry. |
Used to identify the patient for the purpose of determining eligibility for brachytherapy reimbursement and for health system planning. |
||
Patient |
Patient Date of Birth |
The date of birth of the patient requesting brachytherapy reimbursement. |
DATE |
DD-MM-YYYY. |
Used to identify the patient for the purpose of determining eligibility for brachytherapy reimbursement and for health system planning. |
||
Patient |
Date of Prostate Biopsy |
The date the prostate biopsy was performed that lead to a treatable cancer diagnosis. |
DATE |
DD-MM-YYYY. |
Used to identify the date of diagnosis for the purpose of determining eligibility for brachytherapy reimbursement and for health system planning. |
||
Patient |
Combined Gleason Score |
Prostate cancer grading score. |
NUMBER (2) |
Numeric entry, within the range of 2 to 6. |
Used to ensure that the request for reimbursement fits within the predefined reimbursement guidelines for the purpose of determining eligibility for brachytherapy reimbursement and for health system planning. |
||
Patient |
Clinical Stage |
Clinical stage of the patient. |
VARCHAR2 (2) |
Alphanumeric entry. Refer to Appendix C for the Ontario Health (Cancer Care Ontario) staging policy. |
Used to ensure that the request for reimbursement fits within the predefined reimbursement guidelines for the purpose of determining eligibility for brachytherapy reimbursement and for health system planning. |
||
Patient |
Serum PSA (Prior to Any Hormone Use) |
Prostate specific antigen in serum. |
NUMBER (4,2) |
Numeric values between 0.01 to 10.00, up to 2 decimal places. |
Used to ensure that the request for reimbursement fits within the predefined reimbursement guidelines and health system planning. |
||
Patient |
Neo-adjuvant Hormone Use |
Use of hormone prior to radiation treatment. |
VARCHAR2 (1) |
Y = Yes, or, N = No. |
For patient clinical data for the purpose of determining eligibility for brachytherapy reimbursement and for health system planning. |
||
Patient |
Brachythreapy Indication |
Treatment plan type |
VARCHAR (40) |
Brachytherapy as Monotherapy, Brachythreapy as Boost |
Used to ensure that the request for reimbursement fits within the predefined reimbursement guidelines for the purpose of determining eligibility for brachytherapy reimbursement and for health system planning. |
||
Patient |
Attending Radiation Oncologist |
Name of responsible radiation oncologise |
VARCHAR (40) |
Alphabetic entry. |
Used to identify the attending physician for the purpose of determining eligibility for brachytherapy reimbursement and for health system planning. |
|
|
Patient |
RTOG Study |
Recognized participation in Radiation Therapy Oncology Group studies (RTOG). |
VARCHAR2 (1) |
Y = Yes, or, N = No. |
Used to ensure that the request for reimbursement fits within the predefined reimbursement guidelines for the purpose of determining eligibility for brachytherapy reimbursement and for health system planning. |
|
|
Patient |
Comments |
Comments |
VARCHAR (100) |
Alphabetic entry. |
Used to allow attending radiation oncologist to track comments for the purpose of determining eligibility for brachytherapy reimbursement and for health system planning. |
|